Phase I Study of Bendamustine in Combination with Lenalidomide (CC-501 3) and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Bendamustine (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions
- 13 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Oct 2014 Planned End Date changed from 1 Jun 2014 to 1 Mar 2015, according to the the ClinicalTrials.gov record.
- 15 Jan 2014 Planned End Date changed from 1 Jan 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.